Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bayer
Pharma
JPM25: Bayer gears up for 'must-win battles' amid Xarelto decline
Potential launches of the ATTR-CM drug acoramidis and the menopause med elinzanetant are what Stefan Oelrich called “must-win battles” at Bayer.
Angus Liu
Jan 15, 2025 8:00pm
Wegovy and Zepbound tipped to fuel $20B heart failure boom
Jan 7, 2025 11:12am
Recapping Fierce Pharma's top stories of the year
Dec 23, 2024 3:00am
Eylea HD passes test in retinal vein occlusion, teeing up filing
Dec 18, 2024 8:20am
Key drugs from Merck, Bayer and Gilead win EMA backing
Dec 13, 2024 10:33am
BMS cuts 195 jobs, bringing head count reduction to 1,329 in NJ
Nov 25, 2024 12:59pm
